The drug is chasing a market where Lilly and Boehringer Ingelheim’s Jardiance (empagliflozin) SGLT2 inhibitor looks likely to be the new pacesetter. It became the first ever diabetes drug to ...

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

Medicare will negotiate drug prices for popular medications like Ozempic and Wegovy, aiming to save billions for taxpayers ...

Next up, Tremfya made a triumphant return to the 2024 roundup after falling off the rankings in 2023. The med's return came ...

Big Pharma is again raising the prices for key medications that could save the lives of millions in Georgia and there are ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...

Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.

They included popular blood thinners Xarelto and Eliquis and diabetes drugs Jardiance and Januvia.The savings from the new list prices for those drugs were expected to generate about $6 billion ...